1.
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
by Ronco, Guglielmo, Dr
The Lancet (British edition), 2014, Vol.383 (9916), p.524-532
2.
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of t...
by Wheeler, Cosette M, Dr, Prof
The lancet oncology, 2012, Vol.13 (1), p.100-110
3.
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-b...
by Paavonen, J, Prof
The Lancet (British edition), 2009, Vol.374 (9686), p.301-314
4.
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention
by Lee, Yi-Chia
Gut, 2013, Vol.62 (5), p.676-682
5.
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
by DiTullio, Richard A
Nature, 2005, Vol.434 (7035), p.907-913
6.
Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial
by Kreimer, Aimée R, Dr
The lancet oncology, 2011, Vol.12 (9), p.862-870
7.
Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions
by Wong, Benjamin C Y
Gut, 2012, Vol.61 (6), p.812-818
8.
Rates and Determinants of Oral Human Papillomavirus Infection in Young Men
by EDELSTEIN, Zoe R
Sexually transmitted diseases, 2012, Vol.39 (11), p.860-867
9.
New Technologies in Cervical Cancer Screening
by Gravitt, Patti E
Vaccine, 2008, Vol.26, p.K42-K52
10.
Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine
by LYAKHOVICH, A.
Alimentary pharmacology & therapeutics, 2010, Vol.31 (2), p.202-209
11.
Post-licensure monitoring of HPV vaccine in the United States
by Markowitz, Lauri E
Vaccine, 2010, Vol.28 (30), p.4731-4737
12.
Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis
by Yoshiji, Hitoshi
Journal of gastroenterology, 2013, Vol.49 (10), p.1421-1429
13.
Success of HPV vaccination is now a matter of coverage
by Schiffman, Mark
The lancet oncology, 2012, Vol.13 (1), p.10-12
14.
Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice
by Saxena, Ashish
Cancer letters, 2014, Vol.355 (1), p.141-147
15.
The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions
by Hariri, Susan
Cancer causes & control, 2012, Vol.23 (2), p.281-288
16.
Arabinoxylan-oligosaccharides (AXOS) reduce preneoplastic lesions in the colon of rats treated with 1,2-dimethylhydrazine (DMH)
by Femia, Angelo Pietro
European journal of nutrition, 2009, Vol.49 (2), p.127-132
17.
The inhibitory effects of mangiferin, a naturally occurring glucosylxanthone, in bowel carcinogenesis of male F344 rats
by YOSHIMI, Naoki
Cancer letters, 2001, Vol.163 (2), p.163-170
19.
Modifying effects of ferulic acid on azoxymethane-induced colon carcinogenesis in F344 rats
by Kawabata, Kunihiro
Cancer letters, 2000, Vol.157 (1), p.15-21
20.
Review article: Helicobacter pylori eradication for the prevention of gastric cancer
by de Vries, Annemarie
Alimentary pharmacology & therapeutics, 2007, Vol.26 (s2), p.25-35
